NEUARTIGE VERBINDUNGEN

European patent · EP3668853 · In force

Register entry

Publication number
EP3668853
Application number
EP18752172
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 15, 2018
Published
Jun 24, 2020
Granted
Sep 29, 2021
Protection ends at the latest
Aug 14, 2038
Next annual fee due
Aug 31, 2026
IPC classes
C07D 401/04 (2006.01)
A61K 31/4427 (2006.01)
A61K 31/4523 (2006.01)
A61K 31/497 (2006.01)
A61K 31/501 (2006.01)
A61K 31/506 (2006.01)
A61P 31/06 (2006.01)
Priority
EP 17382570 16.08.2017
PCT application
PCT/EP2018/072144 15.08.2018
PCT publication
WO2019/034701 21.02.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 16, 2025

    Corrected

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom, Bioversys AG, Technologiepark Basel, Hochbergerstrasse 60c, 4057 Basel

    Published in Swissreg on 16.12.2025

  2. Nov 7, 2025

    Holder’s address changed

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom, Bioversys AG, Technologiepark Basel, Hochbergerstrasse 60c, 4057 Basel → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

    Published in Swissreg on 07.11.2025

  3. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  4. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  5. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  6. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  7. Aug 10, 2022

    Change

    Published in Swissreg on 10.08.2022

  8. Dec 27, 2021

    Agent entered

    Representative
    AWA Switzerland Ltd., Case Postale 2243, 2800 Delémont 2

    Published in Swissreg on 27.12.2021

1 earlier entry
  1. Sep 29, 2021

    Granted

    Published in Swissreg on 29.09.2021

Parties

Holder

GlaxoSmithKline Intellectual Property Development Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage, SG1 2NY, GB

BioVersys AG

Bioversys AG

Technologiepark Basel Hochbergerstrasse 60c, 4057 Basel

Agent

AWA Switzerland SA

AWA Switzerland Ltd.

Case Postale 2243, 2800 Delémont 2

Inventor

DEPREZ, Benoit

59000 Lille, FR

REMUIÑAN-BLANCO, Modesto Jesús

28760 Madrid, ES

WILLAND, Nicolas

59000 Lille, FR

PORRAS DE FRANCISCO, Esther

28760 Madrid, ES

BOUROTTE, Marilyne

59840 Perenchies, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.